While lung cancer is not traditionally classified as hormone-dependent, ESR1 signaling has been implicated in tumor proliferation, survival, and metastasis through estrogen-mediated pathways, with overexpression correlating with poor prognosis in certain subtypes [62]. Here, ESR1 is linked to neoplasm.